carcinomat

Carcinomat is not a standard term in modern medical English. When encountered, it is usually an incomplete form of carcinoma or a stem used in related words such as carcinomatous. The correct term for a malignant tumor arising from epithelial tissue is carcinoma, while carcinomatous describes tissue or conditions related to such tumors.

Carcinomas arise from epithelial cells that line organs, glands, or body surfaces. They are among the most common forms of cancer and can occur in many tissues, including the skin, lungs, breast, colon, and prostate. Major histological subtypes include squamous cell carcinoma (originating from flat, scale-like cells), adenocarcinoma (gland-forming), and transitional (urothelial) carcinoma, among others. The histology and molecular features guide classification and treatment decisions.

Pathology and diagnosis typically rely on histopathologic examination of tissue obtained by biopsy or surgery. Carcinomas show malignant epithelial cells with abnormalities in shape and organization, invasion into surrounding tissues, and variable mitotic activity. Immunohistochemical staining helps determine the tissue of origin and subtype, using markers such as cytokeratins and other lineage-specific proteins. Imaging studies aid in staging and assessment of spread, including lymphatic involvement and distant metastases.

Clinical management and prognosis are driven by the cancer site, stage at diagnosis, histologic grade, and molecular characteristics. Treatment usually involves a combination of surgery, radiotherapy, and systemic therapies such as chemotherapy, targeted therapy, or immunotherapy, chosen according to the tumor type and stage. Early detection and complete surgical removal offer the best outcomes for many carcinomas, while advanced cases depend on multimodal approaches and supportive care.